Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q3 2025 Earnings Call Transcript November 3, 2025
Syndax Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.7, expectations were $-0.74.
Operator: Good day, everyone, and welcome to the Syndax Third Quarter 2025 Earnings Conference Call. Today’s call is being recorded. [Operator Instructions] At this time, I would like to turn the call over to Sharon Klahre, Head of Investor Relations at Syndax Pharmaceuticals.
Sharon Klahre:...
